![](/img/cover-not-exists.png)
Individualized quantification of brain β-amyloid burden: results of a proof of mechanism phase 0 florbetaben PET trial in patients with Alzheimer’s disease and healthy controls
Henryk Barthel, Julia Luthardt, Georg Becker, Marianne Patt, Eva Hammerstein, Kristin Hartwig, Birk Eggers, Bernhard Sattler, Andreas Schildan, Swen Hesse, Philipp M. Meyer, Henrike Wolf, Torsten ZimmVolume:
38
Language:
english
Pages:
13
DOI:
10.1007/s00259-011-1821-1
Date:
September, 2011
File:
PDF, 1.42 MB
english, 2011